Alimera Sciences
AcquiredFocused on diseases affecting the retina
Alpharetta, United States · Founded 2003
- Headquarters
- Alpharetta, Georgia
- Employees
- 51–200
- Founded
- 2003
- Business Model
- B2B
- Website
- alimerasciences.com
- Last Round
- Venture RoundFeb 2014
- Rounds
- 2
- Acquired by
- ANI PharmaceuticalsJun 2024
About
Alimera Sciences was a global pharmaceutical company focused on diseases affecting the retina. Its flagship product, ILUVIEN, is a sustained-release intravitreal implant approved for diabetic macular edema and non-infectious uveitis. The company served patients and physicians across the US and international markets before being acquired by ANI Pharmaceuticals in September 2024.
Summary
Alimera Sciences is a Biotech company based in Alpharetta, United States, founded in 2003. Its most recent funding was a Venture Round in Feb 2014. Investors include ANI Pharmaceuticals, Palo Alto Investors and Sofinnova Partners.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Jun 2024
Sign up to see all 4 events
Funding: Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alimera-sciences"><img src="https://indexed.vc/api/badge/company/alimera-sciences" alt="Alimera Sciences on Indexed.vc" width="260" height="76" /></a>